- Home
- COOK vs BIOA Comparison
COOK vs BIOA Comparison
Compare COOK & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COOK | BIOA |
|---|---|---|
| Founded | 1985 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.8M | 175.7M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | COOK | BIOA |
|---|---|---|
| Price | $0.91 | $12.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $2.04 | ★ $11.33 |
| AVG Volume (30 Days) | ★ 675.8K | 294.4K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $582,799,000.00 | $5,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $2.88 |
| 52 Week High | $3.31 | $12.30 |
Technical Indicators
Market Signals| Indicator | COOK | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 80.56 |
| Support Level | $0.71 | $8.46 |
| Resistance Level | $0.84 | $9.62 |
| Average True Range (ATR) | 0.09 | 0.65 |
| MACD | 0.01 | 0.28 |
| Stochastic Oscillator | 60.08 | 94.37 |
Price Performance
Historical ComparisonAbout COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.